<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04593797</url>
  </required_header>
  <id_info>
    <org_study_id>NL64436.018.17</org_study_id>
    <nct_id>NCT04593797</nct_id>
  </id_info>
  <brief_title>Echo FLOW Versus (Non-)Invasive Haemodynamics</brief_title>
  <acronym>EFLOW</acronym>
  <official_title>The Accuracy of Ultrasound Derived Carotid, Femoral and Brachial Artery Compared to Conventional Intra-vascular Methods Flow-related Parameters</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Philips Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Diligent fluid management is instrumental to improve postoperative outcome, cost&#xD;
      and quality of care.&#xD;
&#xD;
      Objective: To determine the accuracy of brachial, femoral and carotid blood flow measurement&#xD;
      with ultrasound compared to intermittent transpulmonary thermodilution cardiac output&#xD;
      measurement, invasive and non-invasive pulse-contour analysis.&#xD;
&#xD;
      Study design: Observational study - Prospective clinical non-intervention measurement study.&#xD;
&#xD;
      Study population: Adult ASA 1-2 patients, scheduled for open upper GI surgery Intervention&#xD;
      (if applicable): Not applicable. We will perform non-invasive ultrasound measurements of the&#xD;
      femoral, carotid and brachial blood flow right before induction and under anaesthesia.&#xD;
&#xD;
      Main study parameters/endpoints: Femoral, carotid and brachial blood flow determined by&#xD;
      ultrasound and blood flow variation and the accuracy compared to transpulmonary&#xD;
      thermodilution cardiac output, stroke volume variation, and pulse-contour analysis derived&#xD;
      cardiac output (invasive or non-invasive) at the following time points during surgery;&#xD;
      (limited for femoral site as it cannot be measured during surgery): (1) before induction of&#xD;
      anaesthesia, (2) after induction, (3) 15 minutes after start of surgery, (4) before and (5)&#xD;
      after (1-2 minutes) a fluid bolus, (6) before and (7) after start of vasopressors, (8) before&#xD;
      and (9) after Trendelenburg position and (10) after surgery before end of anaesthesia (figure&#xD;
      1). A fluid bolus will be performed as part of standard care (goal-directed fluid therapy).&#xD;
      The vasopressor and Trendelenburg position time points are optional measurements. We will&#xD;
      also measure (continuous) invasive femoral blood pressure (SBP, DBP, MAP), non-invasive blood&#xD;
      pressure, SVV, central venous pressure (when available), heart rate, SpO2, PFI, etCO2.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Actual">January 9, 2019</completion_date>
  <primary_completion_date type="Actual">January 9, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiac output</measure>
    <time_frame>baseline</time_frame>
    <description>blood flow determined by ultrasound and the accuracy compared to transpulmonary thermodilution calibrated continuous cardiac output</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac output change</measure>
    <time_frame>change from baseline cardiac output 1 minute after intervention (fluid challenge, vasopressor administration, or Trendelenburg)</time_frame>
    <description>Change in blood flow compared to change in cardiac output</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Cardiac Output, Low</condition>
  <condition>Cardiac Output, High</condition>
  <arm_group>
    <arm_group_label>Patients undergoing major upper abdominal surgery</arm_group_label>
    <description>major open upper abdominal surgery eg pancreatic, liver surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>carotid blood flow measurement with ultrasound</intervention_name>
    <description>carotid blood flow measurement with ultrasound vs transpulmonary thermodilution calibrated continuous cardiac output measurements</description>
    <arm_group_label>Patients undergoing major upper abdominal surgery</arm_group_label>
    <other_name>transpulmonary thermodilution calibrated continuous cardiac output measurements</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients, scheduled for open upper GI surgery with a American Society of&#xD;
        Anaesthesiologist score of 1 to 2&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective open GI surgery&#xD;
&#xD;
          -  Invasive arterial blood pressure monitoring&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant stenosis &gt; 30% or abnormal anatomy of aortic, femoral, carotid or brachial&#xD;
             artery&#xD;
&#xD;
          -  Cerebrovascular accident&#xD;
&#xD;
          -  Atrial fibrillation&#xD;
&#xD;
          -  COPD stage 3-4&#xD;
&#xD;
          -  Lobectomy / pneumectomy&#xD;
&#xD;
          -  Active pneumonia&#xD;
&#xD;
          -  Cardiac failure&#xD;
&#xD;
          -  Severe heart valve regurgitation or stenosis&#xD;
&#xD;
          -  Not able to measure brachial or carotid artery blood flow during surgery&#xD;
&#xD;
          -  Contra-indications for femoral arterial catheter placement (e.g., vascular graft)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>A.P. Vlaar, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amsterdam UMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Academisch Medisch Centrum - Universiteit van Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 29, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 19, 2020</last_update_submitted>
  <last_update_submitted_qc>October 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>A.P.J. Vlaar</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiac Output, Low</mesh_term>
    <mesh_term>Cardiac Output, High</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Plan to make individual available upon request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

